The global blood transfusion diagnostic market was valued at USD 4.4 billion in 2021 and it is anticipated to grow further till USD 8.7 Billion by 2031, at a CAGR of 7.1% during the forecast period.
Tests that are carried out on blood and blood components before they are administered to patients are referred to as blood transfusion diagnostics. In order to avoid negative responses or the spread of any infections, blood units must undergo blood group typing and disease screening tests. It is an essential component of transfusion therapy that checks the compatibility of blood samples from donors and recipients and gives medical practitioners valuable information.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10419
Market Trends and Drivers
One of the factors driving the demand for blood transfusions is the rising prevalence of chronic and infectious diseases like severe anaemia, cancer, haemophilia, kidney, liver, severe infection, sickle cell disease, and thrombocytopenia as well as the introduction of technologically advanced products. Anemia is one of the most prevalent blood-related disorders, affecting over 3 million people in the United States, and the majority of cases are caused by iron deficiency, according to the National Heart, Lung, and Blood Institute.
Donor screening is in high demand because to the rising danger of transfusion-transmitted infections (TTIs). Donor screening is becoming more and more important in order to protect patients from unsuitable blood and blood products and fight TTIs. TTI testing has become a required routine in a number of nations, including the UAE, South Africa, and the US. Thus, it is anticipated that a variety of variables, including the increase in TTI cases and the underdiagnosis of affected donors, will significantly influence the blood transfusion diagnostics market.
Get A Customized Scope to Match, Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10419
Global Blood Transfusion Diagnostics Market
- Kits & Reagents
- Blood Screening
- Blood Group Typing
By End User
- Hospital-based Laboratories
- Independent Laboratories & Blood Banks
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/checkout/single_user/GIS10419
Major Players in the Global Blood Transfusion Diagnostics Market
The key players studied in the report are Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, and BIO KIT (Werfen) among others.
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.